Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 19 Endometrial Neoplasms 15 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Breast Neoplasms 5 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Melanoma 4 Lung Neoplasms 4 Colonic Neoplasms 4 Fallopian Tube Neoplasms 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Osteosarcoma 2 Multiple Myeloma 2 Locally Advanced Rectal Cancer (LARC) 2 Carcinoma, Renal Cell 2 Carcinoma, Neuroendocrine 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Turcot syndrome 1

Interventions

pembrolizumab 10 Nivolumab 9 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 toripalimab 2 sintilimab 2 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 Celecoxib 2 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 danvatirsen 1 camrelizumab 1 XELOX 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × dostarlimab × Clear all

NCT06278857 2024-12-03

SATELLITE

Queensland Centre for Gynaecological Cancer

Phase 2 Recruiting

Turcot syndrome, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡